Roche
ROG.SW
#39
Rank
NZ$558.90 B
Marketcap
NZ$702.47
Share price
0.79%
Change (1 day)
20.40%
Change (1 year)

EPS for Roche (ROG.SW)

EPS in 2025: NZ$35.38

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$35.38. In 2025 the company made an earnings per share (EPS) of NZ$35.38 an increase over its 2024 EPS that were of NZ$19.92.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$35.3877.67%
2024NZ$19.92-32.84%
2023NZ$29.651.95%
2022NZ$29.09-6.29%
2021NZ$31.04-5.53%
2020NZ$32.8616.56%
2019NZ$28.1930.3%
2018NZ$21.6320.22%
2017NZ$17.99-5.81%
2016NZ$19.104.62%
2015NZ$18.26-5.13%
2014NZ$19.25-25.05%
2013NZ$25.6821.73%
2012NZ$21.103.82%
2011NZ$20.328.16%
2010NZ$18.7923.72%
2009NZ$15.18-12.31%
2008NZ$17.31-0.34%
2007NZ$17.3732.13%
2006NZ$13.1542.56%
2005NZ$9.22-22.7%
2004NZ$11.93132.85%
2003NZ$5.12-147.39%
2002NZ-$10.81-209.09%
2001NZ$9.91-57.03%
2000NZ$23.0753.29%
1999NZ$15.0531.24%
1998NZ$11.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.28-45.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.74-63.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.35-93.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.49-81.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.81-29.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.58-89.89%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.64-72.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.65-64.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.52-81.56%๐Ÿ‡ฌ๐Ÿ‡ง UK